About the webinar :
The world of drug discovery is undergoing a remarkable shift, and at the forefront of this change lies the exciting realm of RNA modulation with small molecules. This innovative approach offers a powerful tool for tackling so called undruggable proteins, presenting a potential paradigm shift in drug discovery.
In this two-part free webinar series, we’ve assembled a team of leading experts who will delve into the intricacies of RNA modulation, explore its potential applications, and showcase real-world case studies.
Key learning objectives:
- Gain insights into how RNA functions and how it can be targeted for therapeutic purposes.
- Explore how these versatile tools can be used to modulate RNA function and potentially treat various diseases.
- Gain a glimpse into the exciting potential of RNA modulation and its ability to revolutionize healthcare.
PART 1 – Wednesday 27th March at 9 am CET | 5pm JST
Dr. Ella Morishita (Veritas In Silico)
« Targeting the RNA with small molecules: Tips and best practices »
Dr. Maria Duca (Université de Côte d’Azur)
« Targeting of non-coding RNAs using synthetic small molecules »
PART 12- Tuesday 23th April at 10 am EDT | 4pm CEST
Peng Wu (Max Planck Institute)
“RNA-protein interaction modulation by small molecules targeting RNA-binding proteins »
Dr Nicolas Ancellin, Dr Christophe Parsy (Oncodesign Services) and Dr Gregg Siegal (ZoBio)
“Technology platform to support early preclinical RNA−Small Molecule modulators programs“
